Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

517
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
517
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

1
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
1
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

3
Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
3

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An automated, digital immunoassay on a microfluidic cartridge for on-demand cytokine profiling.

Microsystems & nanoengineering·2026
Same author

The Efficacy and Safety of Weighted Blankets to Reduce Agitation After Cardiac Catheterization and Electrophysiology Procedures in Pediatric Patients With Congenital Heart Disease.

Journal of cardiothoracic and vascular anesthesia·2026
Same author

Characteristics Associated with Poor Long-Term Outcomes in Patients with Fontan Palliation: A Case-Control Study.

Pediatric cardiology·2026
Same author

The FUEL FALD Study: Effects of Udenafil on Liver Stiffness and Fibrosis after Fontan.

Pediatric cardiology·2026
Same author

Cefepime pharmacokinetics in critically ill children with multiple organ dysfunction syndrome using volumetric absorptive microsampling.

Antimicrobial agents and chemotherapy·2026
Same author

The Fontan Outcomes Network: Findings After 2 Years and 1121 Participants.

Circulation·2026

Related Experiment Video

Updated: Jun 6, 2025

Murine Model of Central Venous Stenosis using Aortocaval Fistula with an Outflow Stenosis
06:17

Murine Model of Central Venous Stenosis using Aortocaval Fistula with an Outflow Stenosis

Published on: July 11, 2019

7.3K

Colchicine in post-operative Fontan patients.

Stephanie A Goldstein1, Katherine Nolan2, Kariann Marchetti2

  • 1University of Utah, Primary Children's Hospital, Department of Pediatrics, Division of Pediatric Critical Care, Salt Lake City, UT, USA.

Cardiology in the Young
|December 3, 2024
PubMed
Summary
This summary is machine-generated.

Colchicine treatment in Fontan patients may shorten chest tube drainage and hospital stay. This anti-inflammatory drug may reduce pro-inflammatory cytokines, improving outcomes after the Fontan procedure.

Keywords:
Chest tube drainageColchicineEffusionFontanInflammationSingle ventricle

More Related Videos

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

11.9K
A Chronic Cardiac Ischemia Model in Swine Using an Ameroid Constrictor
08:22

A Chronic Cardiac Ischemia Model in Swine Using an Ameroid Constrictor

Published on: October 9, 2017

10.5K

Related Experiment Videos

Last Updated: Jun 6, 2025

Murine Model of Central Venous Stenosis using Aortocaval Fistula with an Outflow Stenosis
06:17

Murine Model of Central Venous Stenosis using Aortocaval Fistula with an Outflow Stenosis

Published on: July 11, 2019

7.3K
Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

11.9K
A Chronic Cardiac Ischemia Model in Swine Using an Ameroid Constrictor
08:22

A Chronic Cardiac Ischemia Model in Swine Using an Ameroid Constrictor

Published on: October 9, 2017

10.5K

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Clinical Pharmacology

Background:

  • Prolonged effusions and high pro-inflammatory cytokines are common morbidities post-Fontan procedure.
  • Colchicine, an anti-inflammatory agent, has shown efficacy in reducing post-cardiac surgery effusions in adults.
  • This study investigated colchicine's effect on cytokine levels and effusion duration in pediatric Fontan patients.

Purpose of the Study:

  • To evaluate the efficacy of colchicine in reducing pro-inflammatory cytokines and chest tube drainage duration post-Fontan procedure.
  • To assess the impact of colchicine on length of hospital stay in Fontan patients.

Main Methods:

  • A pilot clinical trial involving nine pediatric patients undergoing the Fontan procedure.
  • Patients received daily colchicine starting post-operative day 2, with chest tube fluid analyzed for 17 cytokines.
  • Comparison was made to a historical control cohort (n=25).

Main Results:

  • Patients completing the colchicine protocol showed significantly shorter chest tube drainage (6 vs. 10 days, p=0.007) and length of stay (7 vs. 9 days, p=0.005).
  • Pro-inflammatory cytokine levels trended lower in the colchicine group.
  • No significant difference was observed in the intention-to-treat group.

Conclusions:

  • Colchicine administration in pediatric Fontan patients completing the protocol resulted in shortened chest tube drainage and hospital stay.
  • Reduced pro-inflammatory cytokines may be the underlying mechanism.
  • Further investigation in larger trials is warranted.